Pharmacological prophylaxis of venous thrombo-embolism.
The pathogenesis of venous thrombosis is briefly discussed as a basis for the understanding of preventive measures used in this condition. Prophylaxis in venous thrombosis is then reviewed with emphasis on pharmacological treatment, and more particularly on heparin.
D000721:Ancrod / Q000627:therapeutic use; D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use*; D003911:Dextrans / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007866:Leg; D011183:Postoperative Complications / Q000517:prevention & control; D011655:Pulmonary Embolism / Q000517:prevention & control*; D011817:Rabbits; D013924:Thrombophlebitis / Q000209:etiology / Q000517:prevention & control*
D000925:Anticoagulants; D003911:Dextrans; D006493:Heparin; D000721:Ancrod